CA 125: A useful marker in endometrial carcinoma
- 1 November 1986
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 155 (5) , 1097-1102
- https://doi.org/10.1016/0002-9378(86)90358-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The tumor marker CA 125 is a common constituent of normal cervical mucusAmerican Journal of Obstetrics and Gynecology, 1986
- CA 125 in tumor tissues, cyst fluids, cervical mucus and serumZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- CEA and NCA in Benign and Malignant Breast TumorsAmerican Journal of Clinical Pathology, 1984
- Prognostic factors and changing trends in the treatment of stage I endometrial cancer: A clinical and histopathological study of 182 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- POSTOPERATIVE EXTERNAL IRRADIATION AND PROGNOSTIC PARAMETERS IN STAGE-I ENDOMETRIAL CARCINOMA - CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS1980
- Adenocarcinoma of the endometrium: Its metastatic lymph node potentialGynecologic Oncology, 1976
- TREATMENT OF ADENOCARCINOMA OF THE ENDOMETRIUMObstetrical & Gynecological Survey, 1975